Catriona Yale

Companies

• Akero Therapeutics, Inc.Chief Development Officer Jun 19, 2019 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ATAkero Therapeutics, Inc.0 shares²Dec 9, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Dec 9, 2025Returned to company 47,573 shares of Akero Therapeutics, Inc.²
• Dec 9, 2025Returned to company 27,227 shares of Akero Therapeutics, Inc.²
• Nov 4, 2025Exercised options 4,739 shares at $21.10 of Akero Therapeutics, Inc.³
• Nov 4, 2025Exercised options 3,527 shares at $28.35 of Akero Therapeutics, Inc.³
• Sep 11, 2025Sold 659 shares at $43.02 of Akero Therapeutics, Inc.⁴
• Jul 16, 2025Sold 1,342 shares at $53.47 of Akero Therapeutics, Inc.⁵
• Jul 16, 2025Sold 8,658 shares at $52.87 of Akero Therapeutics, Inc.⁵
• Jul 16, 2025Exercised options 10,000 shares at $19.87 of Akero Therapeutics, Inc.⁵
• Jun 30, 2025Granted 890 shares at $23.87 of Akero Therapeutics, Inc.⁶
• Jun 18, 2025Sold 1,633 shares at $54.84 of Akero Therapeutics, Inc.⁷
• Jun 16, 2025Sold 895 shares at $55.52 of Akero Therapeutics, Inc.⁸
• Jun 16, 2025Sold 2,895 shares at $54.80 of Akero Therapeutics, Inc.⁸
• Jun 16, 2025Sold 6,210 shares at $53.78 of Akero Therapeutics, Inc.⁸
• Jun 16, 2025Exercised options 10,000 shares at $21.10 of Akero Therapeutics, Inc.⁸
• Jun 10, 2025Sold 2,803 shares at $54.00 of Akero Therapeutics, Inc.⁹
• May 15, 2025Sold 4,384 shares at $39.91 of Akero Therapeutics, Inc.¹⁰
• May 15, 2025Sold 2,779 shares at $39.46 of Akero Therapeutics, Inc.¹⁰
• May 15, 2025Sold 2,837 shares at $38.20 of Akero Therapeutics, Inc.¹⁰
• May 15, 2025Exercised options 10,000 shares at $21.10 of Akero Therapeutics, Inc.¹⁰
• Apr 15, 2025Sold 1,200 shares at $38.62 of Akero Therapeutics, Inc.¹¹
• Apr 15, 2025Sold 7,873 shares at $37.80 of Akero Therapeutics, Inc.¹¹
• Apr 15, 2025Exercised options 9,073 shares at $21.10 of Akero Therapeutics, Inc.¹¹
• Mar 17, 2025Sold 1,799 shares at $45.05 of Akero Therapeutics, Inc.¹²
• Mar 17, 2025Sold 8,201 shares at $44.70 of Akero Therapeutics, Inc.¹²
• Mar 17, 2025Exercised options 10,000 shares at $21.10 of Akero Therapeutics, Inc.¹²